Developmental Neurotoxicity of Cannabinoids
Tuesday April 05, 2022
Central Time (CT)
Univ of Washington School of Pharmacy
University at Buffalo
Recent studies have revealed that cannabis is the second most used drug after alcohol in the US. Evidence shows that cannabis use in adolescents and young adults is associated with adverse neurocognitive reactions. Studies also show that cannabis use by pregnant women has been consistently increasing over time. Cannabis use among these special populations is expected to further increase with recent trends toward legalization of recreational consumption, representing a potential but great public health concern. This symposium is therefore timely with respect to understanding neurotoxicity of cannabinoids in infants and adolescents.
- Indiana University
Enduring Molecular, Physiological, and BehavioralEeffects of Perinatal Cannabinoids: Mechanisms and Possible Therapeutic Strategies for their Treatment
Dr. Mackie is an expert in the area of cannabinoid receptors and their roles in the psychoactive and therapeutic actions of cannabis. He will present his recent work on physiological and behavioral effects of perinatal cannabinoids including THC and CBD in animal models.
- Washington University in St. Louis
Associations Between Prenatal Cannabis Exposure and Psychopathological and Neurological Childhood Outcomes
Dr. Bogdan is an expert in understanding how early life adversity and later stress exposure shape risk for mental and physical health outcomes. He will present his recent data on associations between prenatal cannabis use and adverse psychopathological and neurological childhood outcomes
- University of Minnesota
Association between Adolescent Cannabis use and Young-adult Functioning in Three Longitudinal Twin Studies
- University of Washington
Abstract #5135 - P-gp and Bcrp Exert Differential Impacts on Maternal and Fetal Exposure to Tetrahydrocannabinol and Its Major Metabolites in Pregnant Mice